Hesitation towards COVID-19 booster vaccination among dialysis patients: a cross-sectional study in Taizhou, China.

Hesitation towards COVID-19 booster vaccination among dialysis patients: a cross-sectional study in Taizhou, China.

Publication date: Oct 02, 2024

This research aimed to explore hesitation towards the COVID-19 booster vaccine among dialysis patients and study the association between COVID-19 pandemic-induced health behavior and vaccination hesitancy. A self-administered online questionnaire evaluating dialysis patients’ hesitation to take COVID-19 booster vaccination was conducted between March 24 and 22 April 2022 in Taizhou, China. The logistic regression method was applied to identify factors associated with vaccination hesitancy, and all data were analyzed using R software. Of the 365 study participants, 272 (74. 5%) individuals hesitated to take the booster dose. Health behavior was found to be a significant factor for hesitation to take COVID-19 vaccines, with OR (95% CI) of 1. 09 (1. 02-1. 17). Influenza vaccination history was also significantly associated with the hesitation (OR (95% CI) = 0. 39 (0. 21-0. 74)). In addition, participants with higher education levels exhibited lower vaccine hesitancy compared to those with junior secondary or below, with ORs (95% CIs) of 0. 49 (0. 27-0. 91) for senior secondary and 0. 35 (0. 14-0. 89) for junior college or above, respectively. The proportion of hesitancy for taking the booster vaccination of the COVID-19 vaccine was high among dialysis patients. Health behaviors, influenza vaccination history, and education levels were risk factors in their vaccination hesitancy. These findings may aid efforts to help vaccinate people with underlying diseases against future pandemics.

Open Access PDF

Concepts Keywords
April Adult
China Aged
Junior China
Pandemics China
Vaccination COVID-19
COVID-19
COVID-19 Vaccines
COVID-19 Vaccines
Cross-Sectional Studies
Dialysis patient
Female
Health Behavior
Health behavior
Hesitation
Humans
Immunization, Secondary
Male
Middle Aged
Renal Dialysis
SARS-CoV-2
Surveys and Questionnaires
Vaccination
Vaccination Hesitancy

Semantics

Type Source Name
disease MESH COVID-19
disease MESH Influenza
disease IDO history
disease MESH education levels
disease MESH Infectious Diseases
pathway REACTOME Reproduction
drug DRUGBANK Troleandomycin
disease IDO infectivity
drug DRUGBANK Indoleacetic acid
drug DRUGBANK Coenzyme M
disease MESH infections
disease MESH chronic diseases
disease MESH death
disease MESH tics
disease MESH allergies
disease MESH hypertension
disease MESH hyperlipemia
disease MESH fatty liver
disease MESH gout
disease MESH cardiovascular disease
disease MESH cancer
drug DRUGBANK L-Valine
disease MESH hyperuricemia
disease IDO intervention
disease MESH uncertainty
drug DRUGBANK (S)-Des-Me-Ampa
drug DRUGBANK Sulfasalazine
disease IDO country

Original Article

(Visited 1 times, 1 visits today)